# FLUENCY® PLUS in the Treatment of Peripheral Artery Disease

> **NCT04765566** · — · COMPLETED · sponsor: **C. R. Bard** · enrollment: 146 (actual)

## Conditions studied

- Vascular Diseases, Peripheral

## Interventions

- **DEVICE:** Endovascular revascularization of peripheral arteries

## Key facts

- **NCT ID:** NCT04765566
- **Lead sponsor:** C. R. Bard
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-05
- **Primary completion:** 2021-10-31
- **Final completion:** 2022-02-28
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2022-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04765566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04765566, "FLUENCY® PLUS in the Treatment of Peripheral Artery Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04765566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*